Company: LRHC
Filing Date: 2025-09-30
Form Type: 424B3
Source: 0001213900-25-093998
Chunk: 47

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-30
Form: 424B3
Chunk 47
---
 in compliance with the rules and regulations of the Nasdaq Capital
Market (such affirmative approval being referred to herein as the “Stockholder Approval”, and the date such Stockholder Approval
is obtained, the “Stockholder Approval Date”), and the Company is required to use its reasonable best efforts to solicit its
stockholders’ approval of such proposal and to cause the board of directors of the Company to recommend to the stockholders that
they approve such proposal.

<div align='center'>26</div>

Notwithstanding the foregoing, if the Company
is able to obtain the written consent of holders of a majority of the shares of its issued and outstanding Advance Shares to obtain Stockholder
Approval (the “Stockholder Consent”), the Company may satisfy the foregoing obligations under the Amended Facility Agreement
by obtaining such consent and submitting for filing with the SEC a preliminary information statement on Schedule 14C no later than 20
days prior to the Stockholder Meeting Deadline, followed by a definitive information statement on Schedule 14C no later than the timeline
for such filing prescribed by the Exchange Act; provided, however, that if the Company receives a notification from the Nasdaq Capital
Market that the Stockholder Consent must be modified, then the Company shall use its best efforts to provide a new Stockholder Consent.

There are substantial risks to the Company’s stockholders as
a result of the sale and issuance of Advance Shares to the Selling Stockholder under the Amended Facility Agreement. These risks include
the potential for substantial dilution and significant declines in the share price of the Company’s securities. See “Risk Factors - Risks Related to this Offering” elsewhere in this Prospectus.

Conditions to Each Advance under the Facility

The Selling Stockholder’s obligation to accept Advance Notices
that are delivered by the Company in accordance with the terms of the Amended Facility Agreement and to purchase Advance Shares under
the Facility is subject to the satisfaction, at the applicable Advance Notice Date (as defined therein), of certain conditions, including
(among others): (i) the accuracy in all material respects of the representations and warranties of the Company included in the Amended
Facility Agreement; (ii) the registration statement pursuant to which the Selling Stockholder is permitted to utilize a prospectus for
resale of the Advance Shares issuable pursuant to such Advance Notice has been declared effective under the Securities Act by the SEC;
(iii) the Company shall have filed with the SEC in a timely manner all reports, notices and other documents required under the Exchange
Act